blog | Minimed

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, Nasdaq, 2026, Minimed

MiniMed Debuts on Nasdaq as IPO Prophet Signals Align With Weak First-Day Trading

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Mar 6, 2026 5:14:41 PM

MiniMed Group, Inc. (MMED), a diabetes technology company with approximately $2.3 billion in fiscal ...

IPOs, Nasdaq, Medline, 2026, Minimed

MiniMed Group Launches IPO as Scaled $2.3 Billion Revenue Diabetes Technology Business Seeks Nasdaq Listing at Approximately $7–8 Billion Implied Market Capitalization

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 24, 2026 1:04:33 PM

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025